Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Atsuki FukadaTomoyuki FujisawaHironao HozumiKeigo KodaTaisuke AkamatsuYoshiyuki OyamaYasuomi SatakeMitsuru NiwaYusuke KaidaHiroyuki MatsudaKoshi YokomuraNaoki KoshimizuMikio ToyoshimaShiro ImokawaDai HashimotoAkira YoshidaTakahisa GonoMasataka KuwanaYasuhiko YamanoYasuhiro KondohKeita YamashitaMasato MaekawaKazutaka MoriYusuke InoueHideki YasuiYuzo SuzukiMasato KarayamaKazuki FuruhashiNoriyuki EnomotoNaoki InuiTakafumi SudaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Serum IFNλ3 is a promising biomarker for identifying patients at high risk of poor outcomes in anti-MDA5 antibody-positive DM-ILD.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- end stage renal disease
- dendritic cells
- ejection fraction
- chronic kidney disease
- newly diagnosed
- immune response
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- disease activity
- copy number
- type diabetes
- adipose tissue
- cell proliferation
- glycemic control
- genome wide
- systemic lupus erythematosus
- transcription factor
- insulin resistance
- dna methylation
- patient reported
- genome wide identification